| Particulars (Rupees in Crores.) | Mar-2025 | Sept-2024 | Mar-2024 | Sept-2023 | Mar-2023 | 
|---|---|---|---|---|---|
| Gross Sales | 421.55 | 361.2 | 407.28 | 301.98 | 298.23 | 
| Excise Duty | 0 | 0 | 0 | 0 | 0 | 
| Net Sales | 421.55 | 361.2 | 407.28 | 301.98 | 298.23 | 
| Other Operating Income | 0 | 0 | 0 | 0 | 0 | 
| Other Income | 3.55 | 2.67 | 3.14 | 1.32 | 3.5 | 
| Total Income | 425.1 | 363.87 | 410.42 | 303.31 | 301.73 | 
| Total Expenditure | 347.53 | 296.22 | 344.67 | 247.98 | 256.51 | 
| PBIDT | 77.57 | 67.65 | 65.75 | 55.33 | 45.22 | 
| Interest | 9.27 | 9.27 | 11.56 | 11.89 | 11.82 | 
| PBDT | 68.3 | 58.38 | 54.19 | 43.43 | 33.4 | 
| Depreciation | 17.34 | 17 | 15.92 | 15.59 | 16.1 | 
| Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 | 
| Tax | 9.64 | 10 | 8.63 | 6.5 | 0 | 
| Deferred Tax | 4.16 | 1.14 | 1.29 | 0.49 | 3.96 | 
| Reported Profit After Tax | 37.16 | 30.24 | 28.34 | 20.86 | 13.34 | 
| Minority Interest After NP | 0 | 0 | 0 | 0 | 0 | 
| Net Profit after Minority Interest | 38.56 | 30.58 | 28.76 | 21.07 | 7.72 | 
| Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 | 
| Adjusted Profit After Extra-ordinary item | 38.56 | 30.58 | 28.76 | 21.07 | 7.72 | 
| EPS (Unit Curr.) | 4.35 | 3.61 | 3.4 | 2.49 | 0.91 | 
| Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 | 
| Dividend (%) | 0 | 0 | 0 | 0 | 0 | 
| Equity | 8.87 | 8.47 | 8.47 | 8.47 | 8.47 | 
| Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 | 
| Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 | 
| Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 | 
| Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 | 
| Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 | 
| Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 | 
| Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 | 
| Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 | 
| PBIDTM(%) | 18.4 | 18.72 | 16.14 | 18.32 | 15.16 | 
| PBDTM(%) | - | - | - | - | - | 
| PATM(%) | 8.81 | 8.37 | 6.95 | 6.9 | 4.47 | 
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.








 IIFL Customer Care Number
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
 IIFL Capital Services Support WhatsApp Number
+91 9892691696


IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.